• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性自发性荨麻疹中的IFN-γ/IL-6及相关细胞因子:对其致病作用及奥马珠单抗治疗期间变化的评估

IFN-γ/IL-6 and related cytokines in chronic spontaneous urticaria: evaluation of their pathogenetic role and changes during omalizumab therapy.

作者信息

Grieco Teresa, Porzia Alessandra, Paolino Giovanni, Chello Camilla, Sernicola Alvise, Faina Valentina, Carnicelli Giorgia, Moliterni Elisa, Mainiero Fabrizio

机构信息

Dermatologic Clinic, Sapienza University of Rome, Rome, Italy.

Experimental Medicine Department, La Sapienza University of Rome, Rome, Italy.

出版信息

Int J Dermatol. 2020 May;59(5):590-594. doi: 10.1111/ijd.14812. Epub 2020 Feb 12.

DOI:10.1111/ijd.14812
PMID:32048727
Abstract

BACKGROUND

Recent studies highlight that high levels of cytokines may precede the onset of many systemic autoimmune disorders and may also be related to chronic spontaneous urticaria (CSU) activity.

METHODS

Eight patients with CSU candidate to omalizumab therapy were enrolled. Four healthy controls were included with the purpose of comparing baseline cytokine levels. We evaluated serum levels of IFN-γ, IL-2, 4, 6, 8, and 10, TNF-α, and GM-CSF. For the patient group, venous blood samples were drawn at T0, T1 (1 week after first drug administration), T2 (after 3 months), T3 (after 6 months), and in case of relapse. Cytokine levels were measured using the human cytokines 8-plex kit. Disease activity and effect of therapy were calculated by means of Urticaria Activity Score 7.

RESULTS

Higher levels of IL-6 and IFN-γ were found in patients with CSU compared to those observed in the control group. Moreover, a common trend between these cytokines and the clinical history of disease could be hypothesized, with a decrease in levels of IFN-γ and IL-6 following remission of CSU with omalizumab treatment. Levels of other tested cytokines were similar between patients and healthy subjects.

CONCLUSION

IFN-γ and IL-6 are proinflammatory cytokines that are strongly related to autoimmunity. Despite being limited by the small sample size, our data offer new insight into a better understanding of the pathogenesis of CSU and support the need for further investigations.

摘要

背景

近期研究表明,高水平的细胞因子可能先于许多系统性自身免疫性疾病的发作,也可能与慢性自发性荨麻疹(CSU)的活动有关。

方法

招募了8名接受奥马珠单抗治疗的CSU患者。纳入4名健康对照者以比较基线细胞因子水平。我们评估了血清中IFN-γ、IL-2、4、6、8和10、TNF-α以及GM-CSF的水平。对于患者组,在T0、T1(首次给药后1周)、T2(3个月后)、T3(6个月后)以及复发时采集静脉血样本。使用人细胞因子8联检试剂盒测量细胞因子水平。通过荨麻疹活动评分7计算疾病活动度和治疗效果。

结果

与对照组相比,CSU患者中IL-6和IFN-γ水平更高。此外,可以推测这些细胞因子与疾病临床病史之间存在共同趋势,即奥马珠单抗治疗使CSU缓解后,IFN-γ和IL-6水平下降。患者和健康受试者之间其他检测细胞因子的水平相似。

结论

IFN-γ和IL-6是与自身免疫密切相关的促炎细胞因子。尽管受样本量小的限制,我们的数据为更好地理解CSU的发病机制提供了新的见解,并支持进一步研究的必要性。

相似文献

1
IFN-γ/IL-6 and related cytokines in chronic spontaneous urticaria: evaluation of their pathogenetic role and changes during omalizumab therapy.慢性自发性荨麻疹中的IFN-γ/IL-6及相关细胞因子:对其致病作用及奥马珠单抗治疗期间变化的评估
Int J Dermatol. 2020 May;59(5):590-594. doi: 10.1111/ijd.14812. Epub 2020 Feb 12.
2
Inflammatory cytokine levels and changes during omalizumab treatment in chronic spontaneous urticaria.奥马珠单抗治疗慢性自发性荨麻疹时的细胞因子水平和变化。
Arch Dermatol Res. 2024 May 25;316(6):261. doi: 10.1007/s00403-024-02966-6.
3
Case Report: Refractory Chronic Spontaneous Urticaria Treated With Omalizumab in an Adolescent With Crohn's Disease.病例报告:奥马珠单抗治疗克罗恩病青少年难治性慢性自发性荨麻疹
Front Immunol. 2021 Mar 2;12:635069. doi: 10.3389/fimmu.2021.635069. eCollection 2021.
4
Peripheral blood T-cell modulation by omalizumab in chronic urticaria patients.奥马珠单抗对慢性荨麻疹患者外周血 T 细胞的调节作用。
Front Immunol. 2024 Aug 20;15:1413233. doi: 10.3389/fimmu.2024.1413233. eCollection 2024.
5
Omalizumab response correlates with reduced IFN-γ-, IL-10- and IL-31-secreting cells in chronic spontaneous urticaria.奥马珠单抗反应与慢性自发性荨麻疹中分泌γ干扰素、白细胞介素-10和白细胞介素-31的细胞减少相关。
J Eur Acad Dermatol Venereol. 2020 Sep;34(9):2078-2085. doi: 10.1111/jdv.16216. Epub 2020 May 22.
6
Experience with Omalizumab for the treatment of chronic spontaneous urticaria in a tertiary center: real life experience.奥马珠单抗治疗三级中心慢性自发性荨麻疹的经验:真实世界的经验。
Cutan Ocul Toxicol. 2020 Sep;39(3):249-253. doi: 10.1080/15569527.2020.1787432. Epub 2020 Jul 7.
7
Omalizumab in the Treatment of Chronic Urticaria: The Effect of Drug Co-Administration and Co-Morbidities.奥马珠单抗治疗慢性荨麻疹:药物联合用药和合并症的影响。
Antiinflamm Antiallergy Agents Med Chem. 2021;20(1):39-50. doi: 10.2174/1871523019666200203123734.
8
Omalizumab Updosing in Chronic Spontaneous Urticaria: an Overview of Real-World Evidence.奥马珠单抗剂量递增治疗慢性自发性荨麻疹:真实世界证据概述。
Clin Rev Allergy Immunol. 2020 Aug;59(1):38-45. doi: 10.1007/s12016-020-08794-6.
9
Stressful life events, psychiatric comorbidities and serum neuromediator levels in patients with chronic spontaneous urticaria treated with omalizumab.奥马珠单抗治疗慢性自发性荨麻疹患者的应激性生活事件、精神共病和血清神经递质水平。
Allergol Immunopathol (Madr). 2024 May 1;52(3):1-7. doi: 10.15586/aei.v52i3.1015. eCollection 2024.
10
The use of omalizumab for treatment-refractory chronic spontaneous urticaria in a West Australian outpatient cohort.在西澳大利亚门诊队列中,奥马珠单抗治疗难治性慢性自发性荨麻疹的应用。
Intern Med J. 2019 Apr;49(4):526-528. doi: 10.1111/imj.14245.

引用本文的文献

1
Chronic Spontaneous Urticaria Severity Relating to TNF-Alpha Serum Concentration.慢性自发性荨麻疹严重程度与肿瘤坏死因子-α血清浓度的关系
Dermatol Res Pract. 2025 Apr 19;2025:8853778. doi: 10.1155/drp/8853778. eCollection 2025.
2
Clinical and Pathophysiological Tangles Between Allergy and Autoimmunity: Deconstructing an Old Dichotomic Paradigm.过敏与自身免疫之间的临床及病理生理纠葛:解构旧有的二分法范式
Clin Rev Allergy Immunol. 2025 Feb 11;68(1):13. doi: 10.1007/s12016-024-09020-3.
3
Bilastine in Refractory Chronic Spontaneous Urticaria: Disease Control and Cytokine Modulation in an Open-label Prospective Study.
比拉斯汀治疗难治性慢性自发性荨麻疹:一项开放标签前瞻性研究中的疾病控制和细胞因子调节
Indian J Dermatol. 2024 Mar-Apr;69(2):132-136. doi: 10.4103/ijd.ijd_722_23. Epub 2024 Apr 29.
4
Key genes and immune infiltration in chronic spontaneous urticaria: a study of bioinformatics and systems biology.慢性自发性荨麻疹的关键基因和免疫浸润:生物信息学和系统生物学研究。
Front Immunol. 2023 Nov 15;14:1279139. doi: 10.3389/fimmu.2023.1279139. eCollection 2023.
5
Palmatine treats urticaria by reducing inflammation and increasing autophagy.荷叶碱通过减轻炎症和增加自噬来治疗荨麻疹。
Front Immunol. 2023 Nov 14;14:1268467. doi: 10.3389/fimmu.2023.1268467. eCollection 2023.
6
Involvement of and Genes and TNF signaling pathways in mast cell activation and pathogenesis of chronic spontaneous urticaria.和 TNF 信号通路在肥大细胞激活和慢性自发性荨麻疹发病机制中的作用。
Front Immunol. 2023 Aug 14;14:1247432. doi: 10.3389/fimmu.2023.1247432. eCollection 2023.
7
Chronic Urticaria Biomarkers IL-6, ESR and CRP in Correlation with Disease Severity and Patient Quality of Life-A Pilot Study.慢性荨麻疹生物标志物IL-6、血沉和C反应蛋白与疾病严重程度及患者生活质量的相关性——一项初步研究
Biomedicines. 2023 Aug 9;11(8):2232. doi: 10.3390/biomedicines11082232.
8
Biomarkers for Monitoring Treatment Response of Omalizumab in Patients with Chronic Urticaria.用于监测奥马珠单抗治疗慢性荨麻疹患者的治疗反应的生物标志物。
Int J Mol Sci. 2023 Jul 11;24(14):11328. doi: 10.3390/ijms241411328.
9
Genetic Variants Leading to Urticaria and Angioedema and Associated Biomarkers.导致荨麻疹和血管性水肿的遗传变异及其相关生物标志物。
J Allergy Clin Immunol Pract. 2023 Aug;11(8):2286-2301. doi: 10.1016/j.jaip.2023.05.031. Epub 2023 May 30.
10
Changes of Gut Microbiome in Adolescent Patients with Chronic Spontaneous Urticaria After Omalizumab Treatment.奥马珠单抗治疗后慢性自发性荨麻疹青少年患者肠道微生物群的变化
Clin Cosmet Investig Dermatol. 2023 Feb 4;16:345-357. doi: 10.2147/CCID.S393406. eCollection 2023.